EDGAR Verified
Primary Source · SEC.gov

Decheng Capital Global Life Sciences Fund V, L.P.

CIK 0002015545Fund Vehicle2025 vintage506(b), 3(c)(1)

Raised

$452M

Investors

42

Min Invest

$0

AltStreet Analysis

·

Generated from EDGAR primary sources

Decheng Capital Global Life Sciences Fund V, L.P. is a Cayman Islands-domiciled pooled investment fund that has raised $452.0M from 42 investors under Regulation D exemptions 506(b) and 3(c)(1). This amended filing reports capital raised by the fifth vehicle in the Decheng Capital life sciences franchise, with Xiangmin Cui and Yuheng Qiu listed as directors and Decheng Capital Management V (Cayman), LLC serving as promoter.

This fund represents a substantial institutional raise in the longevity and biotech category, utilizing the private 506(b) exemption typical for venture and growth funds in this sector. The $10.8M average commitment per investor and Cayman domicile align with standard offshore structures for U.S.-based managers raising capital from tax-exempt and international LPs.

Data Flags

generalOffshore domicile (Cayman Islands) filing Form D indicates cross-border fund structure
first_sale_dateFirst sale date not disclosed on this amended filing; standard for large institutional vehicles ($452M raised) but limits vintage transparency

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0002015545
Entity NameDecheng Capital Global Life Sciences Fund V, L.P.
Exemption506(b), 3(c)(1)
First Sale Date
Filing DateOctober 3, 2025
Accession Number0001231919-25-000281
Total Amount Sold$452M
Total Investors42
Minimum Investment$0 (no stated minimum)
Securities TypePooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Xiangmin Cui

Director · Grand Cayman, E9

Yuheng Qiu

Director · Grand Cayman, E9

N/A Decheng Capital Management V (Cayman), LLC

Promoter · Grand Cayman, E9

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.